Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BARNAS C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 36 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gutierrez-Lobos, K; Frohlich, S; Quiner, S; Haring, C; Barnas, C
      Prescription patterns and quality of information provided for consumers ofbenzodiazepines

      ACTA MEDICA AUSTRIACA
    2. Kasper, S; Quiner, S; Barnas, C; Fabisch, T; Haushofer, M; Sackel, C; Konig, P; Lingg, A; Platz, T; Rittmannsberger, H; Stuppack, C; Willeit, M; Zapotoczky, HG
      Zotepine in the treatment of acute hospitalized schizophrenic episodes

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    3. Barnas, C; Quiner, S; Tauscher, J; Hilger, E; Willeit, M; Kufferle, B; Asenbaum, S; Brucke, T; Rao, ML; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine 2 receptor occupancyin schizophrenic patients

      PSYCHOPHARMACOLOGY
    4. Cortes, U; Moyret-Lalle, C; Falette, N; Duriez, C; El Ghissassi, F; Barnas, C; Morel, AP; Hainaut, P; Magaud, JP; Puisieux, A
      BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

      MOLECULAR CARCINOGENESIS
    5. Gutierrez-Lobos, K; Frohlich, S; Miller, C; Whitworth, AB; Quiner, S; Barnas, C
      A comparison of patterns of tranquiliser intake, anxiety and health locus of control between short- and long-term benzodiazepine users

      NEUROPSYCHOBIOLOGY
    6. Pezawas, L; Quiner, S; Moertl, D; Tauscher, J; Barnas, C; Kufferle, B; Wolf, R; Kasper, S
      Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    7. Krecic-Shepard, ME; Park, K; Barnas, C; Slimko, J; Kerwin, DR; Schwartz, JB
      Race and sex influence clearance of nifedipine: Results of a population study

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    8. Kasper, S; Tauscher, J; Kufferle, B; Barnas, C; Pezawas, L; Quiner, S
      Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    9. Kapitan, T; Schindl, M; Schindler, SD; Hesselmann, B; Fureder, T; Barnas, C; Sieghart, W; Kasper, S
      The citalopram challenge test in patients with major depression and in healthy controls

      PSYCHIATRY RESEARCH
    10. Tauscher, J; Kufferle, B; Asenbaum, S; Fischer, P; Pezawas, L; Barnas, C; Tauscher-Wisniewski, S; Brucke, T; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

      PSYCHOPHARMACOLOGY
    11. KASPER S; TAUSCHER J; KUFFERLE B; HESSELMANN B; BARNAS C; BRUCKE T
      IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS

      European psychiatry
    12. KAPITANY T; MESZAROS K; LENZINGER E; SCHINDLER SD; BARNAS C; FUCHS K; SIEGHART W; ASCHAUER HN; KASPER S
      GENETIC POLYMORPHISMS FOR DRUG-METABOLISM (CYP2D6) AND TARDIVE-DYSKINESIA IN SCHIZOPHRENIA

      Schizophrenia research
    13. WILLEIT M; BARNAS C; TAUSCHER J; KUFFERLE B; KRENN P; ASENBAUM S; BRUCKE T; KASPER S
      VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE

      Schizophrenia research
    14. GRATAS C; TOHMA Y; BARNAS C; TANIERE P; HAINAUT P; OHGAKI H
      UP-REGULATION OF FAS (APO-1 CD95) LIGAND AND DOWN-REGULATION OF FAS EXPRESSION IN HUMAN ESOPHAGEAL CANCER/

      Cancer research
    15. KASPER S; TAUSCHER J; KUFFERLE B; BARNAS C; HESSELMANN B; ASENBAUM S; PODREKA I; BRUCKE T
      SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY

      Psychopharmacology
    16. KASPER S; BARNAS C; HEIDEN A; VOLZ HP; LAAKMANN G; ZEIT H; PFOLZ H
      PRAMIPEXOLE AS ADJUNCT TO HALOPERIDOL IN SCHIZOPHRENIA SAFETY AND EFFICACY

      European neuropsychopharmacology
    17. PRASCHAKRIEDER N; NEUMEISTER A; HESSELMANN B; WILLEIT M; BARNAS C; KASPER S
      SUICIDAL TENDENCIES AS A COMPLICATION OF LIGHT THERAPY FOR SEASONAL AFFECTIVE-DISORDER - A REPORT OF 3 CASES

      The Journal of clinical psychiatry
    18. BARNAS C; MARTELPLANCHE G; FURUKAWA Y; HOLLSTEIN M; MONTESANO R; HAINAUT P
      INACTIVATION OF THE P53 PROTEIN IN CELL-LINES DERIVED FROM HUMAN ESOPHAGEAL CANCERS

      International journal of cancer
    19. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL

      Biological psychiatry
    20. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE

      Biological psychiatry
    21. KASPER S; KUFFERLE B; TAUSCHER J; ASENBAUM S; BARNAS C; HESSELMANN B; PODREKA I; BRUCKE T
      DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS

      Biological psychiatry
    22. ELLMEIER W; BARNAS C; KOBRNA A; KLEINER E; KURZBAUER R; WEITH A
      CLONING AND CHARACTERIZATION OF CPG ISLANDS OF THE HUMAN-CHROMOSOME 1P36 REGION

      Genomics
    23. KASPER S; TAUSCHER J; KUFFERLE B; HEIDEN A; NEUMEISTER A; BARNAS C; ASENBAUM S; PODREKA I; BRUCKE T
      D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS

      Biological psychiatry
    24. KAPITANY T; HESSELMANN B; SCHINDLER SD; BARNAS C; SIEGHART W; KASPER S
      NEUROENDOCRINE RESPONSES TO THE CITALOPRAM CHALLENGE TEST IN DEPRESSION

      Biological psychiatry
    25. SCHINDLER SD; KAPITANY T; HELLELMANN B; BARNAS C; SIEGHART W; KASPER S
      BLUNTED NEUROENDOCRINE RESPONSE TO CITALOPRAM CHALLENGE IN DIABETES (TYPE-1)

      Biological psychiatry
    26. MILLER CH; SIMIONI I; OBERBAUER H; SCHWITZER J; BARNAS C; KULHANEK F; BOISSEL KE; MEISE U; HINTERHUBER H; FLEISCHHACKER WW
      TARDIVE-DYSKINESIA PREVALENCE RATES DURING A 10-YEAR FOLLOW-UP

      The Journal of nervous and mental disease
    27. SCHINDLER S; BARNAS C; LEITNER H; KAPITANY T; KASPER S
      TRIGEMINAL NEURALGIC SYNDROME AFTER BRIGHT LIGHT THERAPY

      The American journal of psychiatry
    28. STUPPAECK CH; BARNAS C; FALK M; GUENTHER V; HUMMER M; OBERBAUER H; PYCHA R; WHITWORTH AB; FLEISCHHACKER WW
      ASSESSMENT OF THE ALCOHOL-WITHDRAWAL SYNDROME - VALIDITY AND RELIABILITY OF THE TRANSLATED AND MODIFIED CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE (CIWA-A)

      Addiction
    29. STUPPAECK CH; BARNAS C; SCHWITZER J; FLEISCHHACKER WW
      CARBAMAZEPINE IN THE PROPHYLAXIS OF MAJOR DEPRESSION - A 5-YEAR FOLLOW-UP

      The Journal of clinical psychiatry
    30. HUMMER M; KURZ M; BARNAS C; SARIA A; FLEISCHHACKER WW
      CLOZAPINE-INDUCED TRANSIENT WHITE BLOOD-COUNT DISORDERS

      The Journal of clinical psychiatry
    31. BARNAS C; BERGANT A; HUMMER M; SARIA A; FLEISCHHACKER WW
      CLOZAPINE CONCENTRATIONS IN MATERNAL AND FETAL PLASMA, AMNIOTIC-FLUID, AND BREAST-MILK

      The American journal of psychiatry
    32. STUPPAECK C; BARNAS C; SCHWITZER J; FLEISCHHACKER WW
      THE ROLE OF CARBAMAZEPINE IN THE PROPHYLAXIS OF UNIPOLAR DEPRESSION

      Neuropsychobiology
    33. PYCHA R; MILLER C; BARNAS C; HUMMER M; STUPPACK C; WHITWORTH A; FLEISCHHACKER WW
      INTRAVENOUS FLUNITRAZEPAM IN THE TREATMENT OF ALCOHOL-WITHDRAWAL DELIRIUM

      Alcoholism, clinical and experimental research
    34. FLEISCHHACKER WW; MILLER CH; BARNAS C; BERGMANN K; PEROVICH R; ALVIR JMJ; LIEBERMAN JA; KANE JM
      THE EFFECT OF ACTIVATION PROCEDURES ON NEUROLEPTIC-INDUCED AKATHISIA

      British Journal of Psychiatry
    35. SPERNERUNTERWEGER B; GAGGL S; FLEISCHHACKER WW; BARNAS C; HEROLD M; GEISSLER D
      EFFECTS OF CLOZAPINE ON HEMATOPOIESIS AND THE CYTOKINE SYSTEM

      Biological psychiatry
    36. BARNAS C; WHITWORTH AB; FLEISCHHACKER WW
      ARE PATTERNS OF BENZODIAZEPINE USE PREDICTABLE - A FOLLOW-UP-STUDY OFBENZODIAZEPINE USERS

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:43:12